Search research articles
Contact Us
Filters
Showing results (131-140 of 140) with videos related to
Page
of 14
Sort By:
You have reached the last page of results.
This site can display upto 140 results.
Mucosal Immunology
|
March 27, 2021
Intestinal CD8<sup>+</sup> T cell responses are abundantly induced early in human development but show impaired cytotoxic effector capacities
R R C E Schreurs, A F Sagebiel, F L Steinert, et al.
BMJ Open
|
November 5, 2020
Exercise for people living with frailty and receiving haemodialysis: a mixed-methods randomised controlled feasibility study
Hannah M L Young, Daniel S March, Patrick J Highton, et al.
Journal of Hypertension
|
May 26, 2026
A literature review of the pharmacokinetic profiles of 20 commonly prescribed antihypertensive medications for use in chemical adherence testing
Randah Alghamdi, Hanad Osman, Patrick J Highton, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
April 5, 2025
A multifactorial intervention to improve cardiovascular outcomes in adults with type 2 diabetes and current or previous diabetic foot ulcer disease: Protocol for a multi-centre randomised control trial (MiFoot study)
Tolu Onuwe, Patrick J Highton, David Batchelor, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 4, 2012
Isosteric replacements for benzothiazoles and optimisation to potent Cathepsin K inhibitors free from hERG channel inhibition
Alexander G Dossetter, Jonathan Bowyer, Calum R Cook, et al.
Genes and Immunity
|
December 13, 2006
Genomic DNA pooling for whole-genome association scans in complex disease: empirical demonstration of efficacy in rheumatoid arthritis
S Steer, V Abkevich, A Gutin, et al.
Journal of Medicinal Chemistry
|
September 19, 2012
Pharmacokinetic benefits of 3,4-dimethoxy substitution of a phenyl ring and design of isosteres yielding orally available cathepsin K inhibitors
James J Crawford, Peter W Kenny, Jonathan Bowyer, et al.
Nature Communications
|
February 17, 2021
Fast acting allosteric phosphofructokinase inhibitors block trypanosome glycolysis and cure acute African trypanosomiasis in mice
Iain W McNae, James Kinkead, Divya Malik, et al.
Journal of Medicinal Chemistry
|
June 30, 2012
(1R,2R)-N-(1-cyanocyclopropyl)-2-(6-methoxy-1,3,4,5-tetrahydropyrido[4,3-b]indole-2-carbonyl)cyclohexanecarboxamide (AZD4996): a potent and highly selective cathepsin K inhibitor for the treatment of osteoarthritis
Alexander G Dossetter, Howard Beeley, Jonathan Bowyer, et al.
Journal of Medicinal Chemistry
|
August 4, 2018
Discovery of a Potent and Orally Bioavailable Cyclophilin Inhibitor Derived from the Sanglifehrin Macrocycle
Richard L Mackman, Victoria A Steadman, David K Dean, et al.
Page
of 14
Search research articles
Search
Showing results (131-140 of 140) with videos related to
Sort By:
Page
of 14
You have reached the last page of results.
This site can display upto 140 results.
Mucosal Immunology
|
March 27, 2021
Intestinal CD8<sup>+</sup> T cell responses are abundantly induced early in human development but show impaired cytotoxic effector capacities
R R C E Schreurs, A F Sagebiel, F L Steinert, et al.
BMJ Open
|
November 5, 2020
Exercise for people living with frailty and receiving haemodialysis: a mixed-methods randomised controlled feasibility study
Hannah M L Young, Daniel S March, Patrick J Highton, et al.
Journal of Hypertension
|
May 26, 2026
A literature review of the pharmacokinetic profiles of 20 commonly prescribed antihypertensive medications for use in chemical adherence testing
Randah Alghamdi, Hanad Osman, Patrick J Highton, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
April 5, 2025
A multifactorial intervention to improve cardiovascular outcomes in adults with type 2 diabetes and current or previous diabetic foot ulcer disease: Protocol for a multi-centre randomised control trial (MiFoot study)
Tolu Onuwe, Patrick J Highton, David Batchelor, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 4, 2012
Isosteric replacements for benzothiazoles and optimisation to potent Cathepsin K inhibitors free from hERG channel inhibition
Alexander G Dossetter, Jonathan Bowyer, Calum R Cook, et al.
Genes and Immunity
|
December 13, 2006
Genomic DNA pooling for whole-genome association scans in complex disease: empirical demonstration of efficacy in rheumatoid arthritis
S Steer, V Abkevich, A Gutin, et al.
Journal of Medicinal Chemistry
|
September 19, 2012
Pharmacokinetic benefits of 3,4-dimethoxy substitution of a phenyl ring and design of isosteres yielding orally available cathepsin K inhibitors
James J Crawford, Peter W Kenny, Jonathan Bowyer, et al.
Nature Communications
|
February 17, 2021
Fast acting allosteric phosphofructokinase inhibitors block trypanosome glycolysis and cure acute African trypanosomiasis in mice
Iain W McNae, James Kinkead, Divya Malik, et al.
Journal of Medicinal Chemistry
|
June 30, 2012
(1R,2R)-N-(1-cyanocyclopropyl)-2-(6-methoxy-1,3,4,5-tetrahydropyrido[4,3-b]indole-2-carbonyl)cyclohexanecarboxamide (AZD4996): a potent and highly selective cathepsin K inhibitor for the treatment of osteoarthritis
Alexander G Dossetter, Howard Beeley, Jonathan Bowyer, et al.
Journal of Medicinal Chemistry
|
August 4, 2018
Discovery of a Potent and Orally Bioavailable Cyclophilin Inhibitor Derived from the Sanglifehrin Macrocycle
Richard L Mackman, Victoria A Steadman, David K Dean, et al.
Page
of 14